Abstract
Small cell carcinoma of the uterine cervix accounts for 1–3% of all cervix cancers. It is an aggressive disease with a poor prognosis. To date, no effective treatment protocol has been determined. Surgery, radiotherapy, and chemotherapy have been used either alone or in combination. Recent data suggests that survival in patients with early staged small cell carcinoma of the cervix is better with surgery combined with chemo-radiotherapy. Here, we presented two patients with stage IB1 small cell carcinoma of the uterine cervix. For both patients, definitive surgery was performed with pelvic and para-aortic lymphadenectomy. Subsequently, they were treated with pelvic external radiotherapy and high-dose-rate intracavitary brachytherapy with concurrent cisplatin based chemotherapy. They were alive with no evidence of disease at 91 and 65 months, respectively.
Similar content being viewed by others
References
Abeler VM, Holm R, Nesland JM, Kjorstad KE (1994) Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 73(3):672–677
Albores-Saavedra J, Gersell D, Gilks CB, Henson DE, Lindberg G, Santiago H et al (1997) Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 121:34–39
Benedet JL, Bender H, Jones H III, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on gynecologic oncology. Int J Gynaecol Obstet 70:209–262
Bermudez A, Vighi S, Garcia A, Sardi J (2001) Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol 82(1):32–39
Boruta DM II, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE (2001) Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 81(1):82–87
Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ (2003) Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 97(3):568–574
Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH (1998) Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 83(4):712–718
Crowder S, Tuller E (2007) Small cell carcinoma of the female genital tract. Semin Oncol 34(1):57–63
Delaloge S, Pautier P, Kerbrat P, Castaigne D, Haie-Meder C, Duvillard P et al (2000) Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. Clin Oncol (R Coll Radiol) 12(6):357–362
Fukuoka M, Furuse K, Saijo N, Nishiwaki Y, Ikegami H, Tamura T et al (1991) Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 83(12):855–861
Hoskins PJ, Wong F, Swenerton KD, Pike JA, Manji M, McMurtrie E et al (1995) Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecol Oncol 56(2):218–225
Iemura K, Sonoda T, Hayakawa A, Abe S, Nemoto N, Adachi I et al (1991) Small cell carcinoma of the uterine cervix showing Cushing’s syndrome caused by ectopic adrenocorticotropin hormone production. Jpn J Clin Oncol 21:293–298
Kim YT, Park SW, Kim JW (2002) Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma. Gynecol Oncol 87:84–89
Mannion C, Park W, Man YG, Zhuang Z, Albores-Saavedra J, Tavassoli FA (1998) Endocrine tumors of the cervix. Cancer 83:1391–1400
Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW et al (1992) Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 47(1):62–65
O’Hanlan KA, Goldberg GL, Jones JG, Runowicz CD, Ehrlich L, Rodriguez-Rodriguez L (1991) Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature. Gynecol Oncol 43(2):167–172
Pazdur R, Bonomi P, Slayton R, Gould VE, Miller A, Jao W et al (1981) Neuroendocrine carcinoma of the cervix: implications for staging and therapy. Gynecol Oncol 12(1):120–128
Petru E, Pasterk C, Reich O, Obermair A, Winter R, Breitenecker G (2005) Small-cell carcinoma of the uterus and the vagina: experience with ten patients. Arch Gynecol Obstet 271(4):316–319
Roth BJ, Johnson DH, Einhorn LH, Schacter LP, Cherng NC, Cohen HJ et al (1992) Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 10(2):282–291
Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR et al (1995) Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 76(10 Suppl):1978–1986
Sheets EE, Berman ML, Hrountas CK, Liao SY, Disaia PJ (1988) Surgically treated, early-stage neuroendocrine small cell cervical carcinoma. Obstet Gynecol 71:10–14
Stoler MH, Mills SE, Gersell DJ, Walker AN (1991) Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 15(1):28–32
Straughn JM Jr, Richter HE, Conner MG, Meleth S, Barnes MN (2001) Predictors of outcome in small cell carcinoma of the cervix-a case series. Gynecol Oncol 83(2):216–220
Sutton GP, Siemers E, Stehman FB, Ehrlich CE (1988) Eaton–Lambert syndrome as a harbinger of recurrent small-cell carcinoma of the cervix with improvement after combination chemotherapy. Obstet Gynecol 72(3):516–518
Sykes AJ, Shanks JH, Davidson SE (1999) Small cell carcinoma of the uterine cervix: a clinicopathological review. Int J Oncol 14(2):381–386
Tabbara IA, Grosh WA, Andersen WA, Taylor PT, Hahn SS, Stewart FM (1990) Treatment of small-cell carcinoma of the cervix with weekly combination chemotherapy. Eur J Cancer 26(6):748–749
Tsunoda S, Jobo T, Arai M, Imai M, Kanai T, Tamura T et al (2005) Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer 15(2):295–300
Ueda G, Shimizu C, Shimizu H, Saito J, Tanaka Y, Inoue M, Tanizawa O (1989) An immunohistochemical study of small- cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers. Gynecol Oncol 34:164–169
Van Nagell JR Jr, Powell DE, Gallion HH, Elliott DG, Donaldson ES, Carpenter AE et al (1988) Small cell carcinoma of the uterine cervix. Cancer 62(8):1586–1593
Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ (2004) Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93(1):27–33
Weed JC Jr, Graff AT, Shoup B, Tawfik O (2003) Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 197(1):44–51
Wistuba II, Gazdar AF, Minna JD (2001) Molecular genetics of small cell lung carcinoma. Semin Oncol 28(2 Suppl 4):3–13
Wolber RA, Clement PB (1991) In situ DNA hybridization of cervical small cell carcinoma and adenocarcinoma using biotin-labeled human Papillomavirus probes. Mod Pathol 4(1):96–100
Acknowledgments
This study was supported by Akdeniz University Scientific Research Projects Unit. The authors thank Sevilay Ezbiderli, M.B.A., for her English-language editorial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korcum, A.F., Aksu, G., Bozcuk, H. et al. Small cell carcinoma of the cervix: a case report. Arch Gynecol Obstet 277, 367–370 (2008). https://doi.org/10.1007/s00404-007-0463-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0463-9